Please ensure Javascript is enabled for purposes of website accessibility



VIVUS Stock Quote

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Interactive Chart

News & Analysis: VIVUS

The Fool has written over 400 articles on VIVUS.


Why VIVUS, Inc. Stock Descended 14% in December

Instead of shrinking waistlines, VIVUS shareholders saw their shares shrink in value by 14% in December. Find out what troubled VIVUS in December and whether or not this dip represents a buying opportunity.